1. Home
  2. CRNX vs NXPLW Comparison

CRNX vs NXPLW Comparison

Compare CRNX & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • NXPLW
  • Stock Information
  • Founded
  • CRNX 2008
  • NXPLW N/A
  • Country
  • CRNX United States
  • NXPLW United States
  • Employees
  • CRNX N/A
  • NXPLW 166
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • NXPLW Telecommunications Equipment
  • Sector
  • CRNX Health Care
  • NXPLW Telecommunications
  • Exchange
  • CRNX Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • CRNX N/A
  • NXPLW N/A
  • IPO Year
  • CRNX 2018
  • NXPLW N/A
  • Fundamental
  • Price
  • CRNX $30.97
  • NXPLW $0.15
  • Analyst Decision
  • CRNX Strong Buy
  • NXPLW
  • Analyst Count
  • CRNX 12
  • NXPLW 0
  • Target Price
  • CRNX $73.36
  • NXPLW N/A
  • AVG Volume (30 Days)
  • CRNX 1.2M
  • NXPLW 6.4K
  • Earning Date
  • CRNX 05-08-2025
  • NXPLW 03-31-2025
  • Dividend Yield
  • CRNX N/A
  • NXPLW N/A
  • EPS Growth
  • CRNX N/A
  • NXPLW N/A
  • EPS
  • CRNX N/A
  • NXPLW N/A
  • Revenue
  • CRNX $1,039,000.00
  • NXPLW $66,482,000.00
  • Revenue This Year
  • CRNX $356.40
  • NXPLW N/A
  • Revenue Next Year
  • CRNX $700.38
  • NXPLW N/A
  • P/E Ratio
  • CRNX N/A
  • NXPLW N/A
  • Revenue Growth
  • CRNX N/A
  • NXPLW 179.89
  • 52 Week Low
  • CRNX $24.10
  • NXPLW $0.25
  • 52 Week High
  • CRNX $62.53
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 46.06
  • NXPLW N/A
  • Support Level
  • CRNX $28.75
  • NXPLW N/A
  • Resistance Level
  • CRNX $30.58
  • NXPLW N/A
  • Average True Range (ATR)
  • CRNX 2.01
  • NXPLW 0.00
  • MACD
  • CRNX 0.34
  • NXPLW 0.00
  • Stochastic Oscillator
  • CRNX 65.36
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: